Skip to content
10-K/A

Annual Report

Carisma Therapeutics Inc.

0001628280-25-020724

← back to feed
Filed
Apr 29, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 26, 2025 41.79M sh